MedTrace Logo

Postextubation High-flow Therapy vs Noninvasive Ventilation in Obese or at High-risk Patients

NCT04125342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2022-03-17

No results posted yet for this study

Summary

The main aim is to demonstrate whether reintubation rate is lower with preventive conditioned noninvasive ventilation (NIV) rather than with High-flow oxygen therapy (HFOT) in obese intermediate-risk patients and in high-risk patients.

Conditions

  • Extubation Failure

Interventions

DEVICE

Preventive Conditioned NIV Therapy after planned extubation

Conditioned NIV during 48 hours following extubation.

DEVICE

Preventive HFOT after planned extubation

HFOT set according to patients tolerance during 48 hours following extubation

Sponsors & Collaborators

  • Hospital Virgen de la Salud

    lead OTHER

Principal Investigators

  • Gonzalo Hernandez · SESCAM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-01
Completion
2021-12-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04125342 on ClinicalTrials.gov